143 related articles for article (PubMed ID: 32750572)
21. [The first psychotic episode].
Vacheron MN
Encephale; 2013 Sep; 39 Suppl 2():S124-5. PubMed ID: 24084423
[No Abstract] [Full Text] [Related]
22. The longitudinal course of schizoaffective disorders. A prospective follow-up study.
Grossman LS; Harrow M; Fudala JL; Meltzer HY
J Nerv Ment Dis; 1984 Mar; 172(3):140-9. PubMed ID: 6699629
[TBL] [Abstract][Full Text] [Related]
23. Effects of a coping-orientated group therapy for schizophrenia and schizoaffective patients: a pilot study.
Andres K; Pfammatter M; Garst F; Teschner C; Brenner HD
Acta Psychiatr Scand; 2000 Apr; 101(4):318-22. PubMed ID: 10782553
[TBL] [Abstract][Full Text] [Related]
24. Distinguishing between first-admission schizophreniform disorder and schizophrenia.
Naz B; Bromet EJ; Mojtabai R
Schizophr Res; 2003 Jul; 62(1-2):51-8. PubMed ID: 12765743
[TBL] [Abstract][Full Text] [Related]
25. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
[TBL] [Abstract][Full Text] [Related]
26. Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
Weiser M; Levi L; Burshtein S; Hagin M; Matei VP; Podea D; Micluția I; Tiugan A; Păcală B; Grecu IG; Noy A; Zamora D; Davis JM
J Clin Psychiatry; 2017 Jul; 78(7):e758-e765. PubMed ID: 28541645
[TBL] [Abstract][Full Text] [Related]
27. [Relationship between insight and self-reported quality of life among shizophrenic patients].
Aghababian V; Auquier P; Baumstarck-Barrau K; Lançon C
Encephale; 2011 Jun; 37(3):162-71. PubMed ID: 21703431
[TBL] [Abstract][Full Text] [Related]
28. A program for relapse prevention in schizophrenia: a controlled study.
Herz MI; Lamberti JS; Mintz J; Scott R; O'Dell SP; McCartan L; Nix G
Arch Gen Psychiatry; 2000 Mar; 57(3):277-83. PubMed ID: 10711914
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the Illness Management and Recovery Scale in schizophrenia and schizoaffective disorder.
Färdig R; Lewander T; Fredriksson A; Melin L
Schizophr Res; 2011 Nov; 132(2-3):157-64. PubMed ID: 21798718
[TBL] [Abstract][Full Text] [Related]
30. Mobile enhancement of motivation in schizophrenia: A pilot randomized controlled trial of a personalized text message intervention for motivation deficits.
Luther L; Fischer MW; Johnson-Kwochka AV; Minor KS; Holden R; Lapish CL; McCormick B; Salyers MP
J Consult Clin Psychol; 2020 Oct; 88(10):923-936. PubMed ID: 32790451
[TBL] [Abstract][Full Text] [Related]
31. Relapse prevention through health technology program reduces hospitalization in schizophrenia.
Homan P; Schooler NR; Brunette MF; Rotondi A; Ben-Zeev D; Gottlieb JD; Mueser KT; Achtyes ED; Gingerich S; Marcy P; Meyer-Kalos P; Hauser M; John M; Robinson DG; Kane JM
Psychol Med; 2023 Jul; 53(9):4114-4120. PubMed ID: 35634965
[TBL] [Abstract][Full Text] [Related]
32. Pilot RCT of bidirectional text messaging for ART adherence among nonurban substance users with HIV.
Ingersoll KS; Dillingham RA; Hettema JE; Conaway M; Freeman J; Reynolds G; Hosseinbor S
Health Psychol; 2015 Dec; 34S(0):1305-15. PubMed ID: 26651472
[TBL] [Abstract][Full Text] [Related]
33. A pilot investigation of the Graduated Recovery Intervention Program (GRIP) for first episode psychosis.
Penn DL; Uzenoff SR; Perkins D; Mueser KT; Hamer R; Waldheter E; Saade S; Cook L
Schizophr Res; 2011 Feb; 125(2-3):247-56. PubMed ID: 20817484
[TBL] [Abstract][Full Text] [Related]
34. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.
Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AF; Staring AB; Mulder CL
Lancet Psychiatry; 2017 Mar; 4(3):199-207. PubMed ID: 28236956
[TBL] [Abstract][Full Text] [Related]
35. Shared decision making PLUS - a cluster-randomized trial with inpatients suffering from schizophrenia (SDM-PLUS).
Hamann J; Holzhüter F; Stecher L; Heres S
BMC Psychiatry; 2017 Feb; 17(1):78. PubMed ID: 28231777
[TBL] [Abstract][Full Text] [Related]
36. The retinoid X receptor agonist bexarotene relieves positive symptoms of schizophrenia: a 6-week, randomized, double-blind, placebo-controlled multicenter trial.
Lerner V; Miodownik C; Gibel A; Sirota P; Bush I; Elliot H; Benatov R; Ritsner MS
J Clin Psychiatry; 2013 Dec; 74(12):1224-32. PubMed ID: 24434091
[TBL] [Abstract][Full Text] [Related]
37. A comparison of schizophrenia, schizoaffective disorder, and bipolar disorder: Results from the Second Australian national psychosis survey.
Mancuso SG; Morgan VA; Mitchell PB; Berk M; Young A; Castle DJ
J Affect Disord; 2015 Feb; 172():30-7. PubMed ID: 25451392
[TBL] [Abstract][Full Text] [Related]
38. The Effects of Psychoeducation on Long-term Inpatients with Schizophrenia and Schizoaffective Disorder.
Yanagida N; Uchino T; Uchimura N
Kurume Med J; 2017 May; 63(3.4):61-67. PubMed ID: 28381728
[TBL] [Abstract][Full Text] [Related]
39. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.
Chow CK; Thiagalingam A; Santo K; Kok C; Thakkar J; Stepien S; Billot L; Jan S; Joshi R; Hillis GS; Brieger D; Chew DP; Rådholm K; Atherton JJ; Bhindi R; Collins N; Coverdale S; Hamilton-Craig C; Kangaharan N; Maiorana A; McGrady M; Shetty P; Thompson P; Rogers A; Redfern J
BMJ Open; 2018 Jan; 8(1):e019463. PubMed ID: 29374674
[TBL] [Abstract][Full Text] [Related]
40. Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.
Subotnik KL; Casaus LR; Ventura J; Luo JS; Hellemann GS; Gretchen-Doorly D; Marder S; Nuechterlein KH
JAMA Psychiatry; 2015 Aug; 72(8):822-9. PubMed ID: 26107752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
